The UK-based CRO RxCelerate continues to expand with its recent acquisition of The Cambridge Partnership for Â1.45m ($1.96m) as it aims to carry out its vision of supporting virtual biotech companies.
Original Article: RxCelerate buys biotech-focused accounting firm, names new CFO